Related Experiment Video
Updated: Jun 4, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
[Cytogenetic study on 53 patients with multiple myeloma]
Yuan Jing1, Mei-Yun Fang, Feng Jiang
1Department of Hematology, Dalian Medical University, Dalian 116011, Liaoning Province, China. jingyuanan@yahoo.com.cn
Conventional cytogenetics and fluorescence in situ hybridization reveal complex chromosomal abnormalities in multiple myeloma (MM). Combining these techniques enhances the detection of genetic aberrations in MM patients.
Area of Science:
- Hematology
- Cancer Genetics
- Cytogenetics
Context:
- Multiple myeloma (MM) is a hematologic malignancy characterized by clonal plasma cell proliferation.
- Understanding the cytogenetic landscape of MM is crucial for diagnosis, prognosis, and treatment strategies.
- Conventional cytogenetic (CC) and molecular cytogenetic techniques offer insights into chromosomal alterations.
Purpose:
- To investigate the conventional and molecular cytogenetic characteristics of multiple myeloma.
- To determine the frequency and types of chromosomal abnormalities in MM.
- To evaluate the utility of fluorescence in situ hybridization (FISH) in detecting these abnormalities.
Summary:
- CC analysis in 53 MM cases revealed a 32.1% rate of chromosomal abnormalities, often complex with 3+ aberrations.
- Key abnormalities included 1q21 amplification, 13q14 deletion, 17p13 deletion, and 14q32 translocation.
- FISH analysis detected abnormalities in MM cases with both normal and abnormal karyotypes, suggesting its complementary role.
Impact:
- Abnormal karyotypes in MM are complex and heterogeneous, highlighting the need for comprehensive cytogenetic analysis.
- FISH improves the detection rate of chromosomal abnormalities in MM compared to CC alone.
- Combining CC and FISH enhances diagnostic capabilities for identifying chromosomal aberrations in MM cytogenetics.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019